Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-01 Sale | 2026-07-02 9:33 pm | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 8,334 | $87.7 | $730,896 | 305,000 (Direct) | View |
| 2026-06-03 Sale | 2026-06-03 9:32 pm | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 8,333 | $75 | $624,975 | 313,334 (Direct) | View |
| 2026-05-01 Sale | 2026-05-01 9:34 pm | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 78,333 | $71.5 | $5,600,701 | 321,667 (Direct) | View |
| 2026-04-01 Sale | 2026-04-03 9:30 pm | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 7,958 | $50 | $397,900 | 87,542 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-01 Exercise | 2026-07-02 9:33 pm | N/A 2034-10-01 | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 8,334 | $0 | 305,000 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-02 9:33 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 8,334 | $27.46 | 305,000 (Direct) | View |
| 2026-06-03 Exercise | 2026-06-03 9:32 pm | N/A 2034-10-01 | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 8,333 | $0 | 313,334 (Direct) | View |
| 2026-06-03 Exercise | 2026-06-03 9:32 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 8,333 | $27.46 | 313,334 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-01 9:34 pm | N/A 2034-10-01 | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 78,333 | $0 | 321,667 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-01 9:34 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 78,333 | $27.46 | 321,667 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 9:30 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 7,958 | $21.66 | 87,542 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 9:30 pm | N/A 2035-01-15 | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 7,958 | $0 | 87,542 (Direct) | View |
| 2026-01-09 Option Award | 2026-01-13 9:26 pm | N/A 2036-01-09 | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2025-01-15 Option Award | 2025-01-17 4:36 pm | N/A 2035-01-15 | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 95,500 | $0 | 95,500 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-01 6:34 pm | N/A 2034-10-01 | Spyre Therapeutics Inc. | SYRE | Sloan Sheldon Chief Medical Officer | 400,000 | $0 | 400,000 (Direct) | View |